TickerFacts.

Neogen Corp (NEOG): Operating Cash Flow

Annual figures by period end, from SEC filings.

$83.20M
Year ended 2026-05-31
+26.6%
3-year compound annual growth
+0.5%
5-year compound annual growth
+8.9%
10-year compound annual growth
$85.88M2010-05-31: $27.99M2011-05-31: $28.84M2012-05-31: $22.28M2013-05-31: $26.56M2014-05-31: $21.67M2015-05-31: $43.79M2016-05-31: $35.33M2017-05-31: $60.27M2018-05-31: $69.13M2019-05-31: $63.84M2020-05-31: $85.88M2021-05-31: $81.09M2022-05-31: $68.04M2023-05-31: $41.03M2024-05-31: $35.30M2025-05-31: $58.20M2026-05-31: $83.20M$83.20M
2010-05-31 Operating Cash Flow (USD) 2026-05-31
Period endedOperating Cash FlowChange YoYSource filing
2026-05-31$83.20M+43.0%2026-07-30, From 2025-06-01
2025-05-31$58.20M+64.9%2026-07-30, From 2024-06-01
2024-05-31$35.30M-14.0%2026-07-30, From 2023-06-01
2023-05-31$41.03M-39.7%2025-07-30, From 2022-06-01
2022-05-31$68.04M-16.1%2024-07-30, From 2021-06-01
2021-05-31$81.09M-5.6%2023-08-15, From 2020-06-01
2020-05-31$85.88M+34.5%2022-07-27, From 2019-06-01
2019-05-31$63.84M-7.7%2021-07-30, From 2018-06-01
2018-05-31$69.13M+14.7%2020-07-30, From 2017-06-01
2017-05-31$60.27M+70.6%2019-07-30, From 2016-06-01
2016-05-31$35.33M-19.3%2018-07-27, From 2015-06-01
2015-05-31$43.79M+102.1%2017-07-28, From 2014-06-01
2014-05-31$21.67M-18.4%2014-07-30, From 2013-06-01
2013-05-31$26.56M+19.2%2014-07-30, From 2012-06-01
2012-05-31$22.28M-22.8%2014-07-30, From 2011-06-01
2011-05-31$28.84M+3.1%2013-07-30, From 2010-06-01
2010-05-31$27.99Mn/a2012-07-30, From 2009-06-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Neogen Corp (NEOG)2026-05-31$83.20M+43.0%
Myriad Genetics Inc (MYGN)2025-12-31$1.80Mn/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$390.14M-28.4%
QuidelOrtho Corp (QDEL)2025-12-28$105.20M+26.7%
Idexx Laboratories Inc (IDXX)2025-12-31$1.18B+27.2%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$394.74Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$8.65Mn/m
Immucell Corp (ICCC)2025-12-31$2.48M+591.6%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.03Mn/m

Compare NEOG, MYGN, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗